Keitaro Nakamoto

820 total citations
63 papers, 557 citations indexed

About

Keitaro Nakamoto is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Physiology. According to data from OpenAlex, Keitaro Nakamoto has authored 63 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 14 papers in Infectious Diseases and 14 papers in Physiology. Recurrent topics in Keitaro Nakamoto's work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Asthma and respiratory diseases (9 papers). Keitaro Nakamoto is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Asthma and respiratory diseases (9 papers). Keitaro Nakamoto collaborates with scholars based in Japan, United States and Israel. Keitaro Nakamoto's co-authors include Haruyuki Ishii, Takeshi Saraya, Hajime Takizawa, Noboru Takayanagi, Yutaka Sugita, Kojiro Honda, Tsutomu Yanagisawa, Takashi Ishiguro, Daisuke Kurai and Mitsuru Sada and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Keitaro Nakamoto

56 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keitaro Nakamoto Japan 13 202 182 119 117 113 63 557
Yotaro Takaku Japan 16 452 2.2× 182 1.0× 370 3.1× 98 0.8× 103 0.9× 58 814
Alexander Wood United Kingdom 13 148 0.7× 99 0.5× 42 0.4× 136 1.2× 101 0.9× 19 545
V. Godding Belgium 10 218 1.1× 142 0.8× 130 1.1× 104 0.9× 57 0.5× 17 504
Kazuma Yagi Japan 17 232 1.1× 427 2.3× 57 0.5× 96 0.8× 278 2.5× 57 812
Christian Herzmann Germany 14 101 0.5× 262 1.4× 88 0.7× 85 0.7× 340 3.0× 37 599
Pamela J. McShane United States 15 739 3.7× 272 1.5× 82 0.7× 46 0.4× 104 0.9× 38 1.0k
James R. Bonner United States 7 128 0.6× 189 1.0× 107 0.9× 95 0.8× 91 0.8× 8 488
Dominique Grenet France 19 687 3.4× 276 1.5× 75 0.6× 79 0.7× 223 2.0× 42 1.2k
Josje Altenburg Netherlands 14 809 4.0× 345 1.9× 173 1.5× 67 0.6× 56 0.5× 54 1.1k
Meral Gültekin Türkiye 16 57 0.3× 174 1.0× 53 0.4× 68 0.6× 91 0.8× 63 652

Countries citing papers authored by Keitaro Nakamoto

Since Specialization
Citations

This map shows the geographic impact of Keitaro Nakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keitaro Nakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keitaro Nakamoto more than expected).

Fields of papers citing papers by Keitaro Nakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keitaro Nakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keitaro Nakamoto. The network helps show where Keitaro Nakamoto may publish in the future.

Co-authorship network of co-authors of Keitaro Nakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Keitaro Nakamoto. A scholar is included among the top collaborators of Keitaro Nakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keitaro Nakamoto. Keitaro Nakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nakamoto, Keitaro, Masato Watanabe, Yuki Yoshida, et al.. (2024). Serum Derivatives–Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma–COPD Overlap: A Prospective Study. Journal of Clinical Medicine. 13(19). 6022–6022. 2 indexed citations
3.
4.
Fukuoka, Kazuhito, Keitaro Nakamoto, Takeshi Saraya, et al.. (2022). Effectiveness of neutralizing antibody cocktail in hemodialysis patients: a case series of 20 patients treated with or without REGN-COV2. Clinical and Experimental Nephrology. 26(5). 476–485. 1 indexed citations
5.
Nakamoto, Keitaro, et al.. (2021). Effects of Norepinephrine Infusion on Cutaneous Surface Temperatures of the Distal Extremities. Southern Medical Journal. 114(3). 180–185.
6.
Nakamoto, Keitaro, Takeshi Saraya, Yuki Yoshida, et al.. (2021). Efficacy and Safety of Weekly Ultraviolet Germicidal Irradiation for the Reuse of N95 Filtering Respirators. Cureus. 13(9). e18233–e18233. 1 indexed citations
7.
Saraya, Takeshi, Manabu Ishida, Kojiro Honda, et al.. (2021). A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients. Medicine. 100(14). e25367–e25367. 1 indexed citations
8.
Nakamoto, Keitaro, et al.. (2021). Chronic pulmonary aspergillosis in a patient with hyper‐IgE syndrome. Respirology Case Reports. 10(1). e0887–e0887. 4 indexed citations
9.
Shirai, Tatsuya, Koji Furuuchi, Keiji Fujiwara, et al.. (2020). Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease. Respiratory Medicine. 166. 105955–105955. 8 indexed citations
10.
Nakamoto, Keitaro, Yuka Sasaki, Tatsuya Shirai, et al.. (2019). ABSTRACT WITHDRAWN. Respirology. 24(S2). 21–21.
11.
Watanabe, Masato, Keitaro Nakamoto, Mitsuru Sada, et al.. (2018). Serum sST2 levels predict severe exacerbation of asthma. Respiratory Research. 19(1). 169–169. 36 indexed citations
12.
Sato, Akinori, Keitaro Nakamoto, Yuki Hatanaka, et al.. (2018). Bosniak Category III Renal Cysts Caused by Crizotinib in an Anaplastic Lymphoma Kinase Gene-Rearranged Non–Small Cell Lung Cancer Patient. Urology. 121. e3–e4. 3 indexed citations
13.
Nakamoto, Keitaro, Takeshi Saraya, & Hajime Takizawa. (2017). Asthma phenotypes: An important step for tailor‐made therapy. Journal of General and Family Medicine. 18(5). 315–316.
14.
Kurashima, Kazuyoshi, Keitaro Nakamoto, Yotaro Takaku, et al.. (2013). CT-diagnosed emphysema and prognosis of chronic airflow obstruction: a retrospective study. BMJ Open. 3(11). e003541–e003541. 5 indexed citations
15.
Nakamoto, Keitaro, Noboru Takayanagi, Tetsu Kanauchi, et al.. (2013). Prognostic Factors in 194 Patients with Chronic Necrotizing Pulmonary Aspergillosis. Internal Medicine. 52(7). 727–734. 38 indexed citations
16.
Tamura, Masaki, Masato Watanabe, Akira Nakajima, et al.. (2013). Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP). Journal of Infection and Chemotherapy. 20(2). 97–103. 25 indexed citations
17.
Saraya, Takeshi, et al.. (2013). Phantom tumour of the lung. BMJ Case Reports. 2013. bcr2013010457–bcr2013010457. 5 indexed citations
18.
Masuda, Midori, Takeshi Morimoto, Noriko Nishimura, et al.. (2003). Measurement of soluble Fcγ receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis. Clinical & Experimental Immunology. 132(3). 477–484. 11 indexed citations
19.
Araki, Koichi, et al.. (2000). Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers. Clinical & Experimental Immunology. 119(2). 259–263. 17 indexed citations
20.
Ohta, Masaharu, et al.. (1990). [Functional diagnosis of tracheal stenosis and tracheoplasty in non-neoplastic disease].. PubMed. 28(2). 265–71.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yotaro Takaku Breakdown of academic impact, for papers by Alexander Wood Breakdown of academic impact, for papers by V. Godding Breakdown of academic impact, for papers by Kazuma Yagi Breakdown of academic impact, for papers by Christian Herzmann Breakdown of academic impact, for papers by Pamela J. McShane Breakdown of academic impact, for papers by James R. Bonner Breakdown of academic impact, for papers by Dominique Grenet Breakdown of academic impact, for papers by Josje Altenburg Breakdown of academic impact, for papers by Meral Gültekin
Rankless by CCL
2026